Advertisement

Topics

electroCore Company Profile

11:47 EST 13th December 2018 | BioPortfolio

electroCore LLC, the New Jersey based bioelectric pharma company, is focused on developing non-invasive vagus nerve stimulation therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology, and respiratory fields. The company’s initial target is the treatment of primary headaches (migraine and cluster headache), and the associated chronic co-morbidities of gastric motility, psychiatric, sleep, and pain disorders that drive disproportionately large direct and indirect costs within the healthcare system and society.


News Articles [31 Associated News Articles listed on BioPortfolio]

electroCore Announces Closing of Initial Public Offering

electroCore (Nasdaq:ECOR) today announced the closing of its initial public offering of 5,200,000 shares of common stock at a public offering price of $15.00 per share. The proceeds from this offering...

IPO could bring in $78M for electroCore

An initial public offering of 5.2 million shares is expected to be priced by electroCore at $15 each in hopes of raising $78  -More- 

FDA grants cluster headache indication for electroCore device

ElectroCore's gammaCore noninvasive vagus nerve stimulation therapy has been granted expanded 510(k) clearance for adjunctive -More- 

$65M IPO priced by electroCore

An initial public offering of 4.3 million shares has been priced by electroCore between $14 and $16 each in hopes of raising  -More- 

electroCore Receives FDA Clearance for gammaCore

electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an expanded label ...

VNS device company electroCore files for IPO

Noninvasive vagus nerve stimulation (nVNS) device company electroCore LLC (focused on neurology and rheumatology) filed for its initial public offering.

U.S. medical device firm electroCore IPO price set at $15 per share

(Reuters) - U.S. medical device maker electroCore Llc's initial public offering is expected to price at $15 per share, Chief Executive Officer Frank Amato told Reuters on Thursday.

Neurology-focused nVNS device company electroCore nets $72.5mm in IPO

Noninvasive vagus nerve stimulation (nVNS) device company electroCore Inc. (focused on neurology and rheumatology) netted $72.5mm in its initial public offering of 5.2mm shares at $15, the midpoint of...

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study.

To evaluate the efficacy, safety, and tolerability of noninvasive vagus nerve stimulation (nVNS; gammaCore; electroCore, LLC, Basking Ridge, NJ) for the acute treatment of migraine in a multicenter, d...

The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue and Immune Responses in Patients With Primary Sjögren's Syndrome.

Primary Sjögren's syndrome (pSS) sufferers have rated chronic fatigue as the most important symptom needing improvement. Emerging data suggest that stimulation of the vagus nerve can modulate immunol...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Closed Loop Vagal Nerve Stimulation for Patients With Posttraumatic Stress Disorder

The tasks of the project are to map the potency and kinetics of the neurologic, autonomic peripheral, inflammatory, and behavioral responses to vagal nerve stimulation (VNS) vs. sham treat...

Companies [2 Associated Companies listed on BioPortfolio]

electroCore LLC

electroCore LLC, the New Jersey based bioelectric pharma company, is focused on developing non-invasive vagus nerve stimulation therapies (the gammaCore device) for the treatment ...

electroCore

electroCore LLC, the New Jersey based bioelectric pharma company, is focused on developing non-invasive vagus nerve stimulation therapies for the treatment of multiple conditions ...

More Information about "electroCore" on BioPortfolio

We have published hundreds of electroCore news stories on BioPortfolio along with dozens of electroCore Clinical Trials and PubMed Articles about electroCore for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of electroCore Companies in our database. You can also find out about relevant electroCore Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record